Newsroom | 24062 results

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced its preliminary, unaudited net sales for the fourth quarter and full year ended December 31, 2025, and reaffirmed its full year 2026 revenue guidance. Preliminary and unaudited total net sales for the fourth quarter of 2025 are expected to be approximately $14...

DUBLIN--(BUSINESS WIRE)--The "CD22 Targeted Therapies Market, Approved Drug Sales, Technology Platforms & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. Report Findings & Highlights: Current & Future Global Market Outlook Insight on CD22 Targeted Approaches Approved Drug Dosage, Price & Sales Insight CD22 Targeted Therapies Development Trends by Region & Indications CD22 Targeted Therapies in Clinical Trials: > 20 Therapies CD22...

PALO ALTO, Calif.--(BUSINESS WIRE)--Period of transformative growth across all major healthcare verticals follows its Series C, which raised $126 million at a $3.5 billion valuation....

SAN FRANCISCO--(BUSINESS WIRE)--Animate Bio reports positive preclinical data showing two AI-designed peptides reduced lung fibrosis & inflammation, with the lead matching nintedanib...

MINNEAPOLIS--(BUSINESS WIRE)--MOBE partners with and invests in Sidekick Health to deliver the first full-risk, integrated platform for managing multiple chronic conditions....

SAN FRANCISCO--(BUSINESS WIRE)--Bunkerhill Health today announced the system-wide deployment of its Carebricks platform at the University of Texas Medical Branch, enabling clinician-led, agentic AI workflows that support care delivery across a health system serving over one million patient visits annually. Over the past year, UTMB Health has moved beyond isolated AI initiatives by deploying Bunkerhill’s Carebricks platform to translate clinician- and operator-led ideas into system-wide action....

MUMBAI, India & DALLAS--(BUSINESS WIRE)--Firstsource Solutions Limited (NSE:FSL, BSE:532809), a leading global provider of business management services and an RP-Sanjiv Goenka Group company, today announced the acquisition of TeleMedik, a Puerto Rico based pioneer in the development and implementation of technological solutions. The acquisition significantly strengthens Firstsource’s end-to-end clinical and utilization management capabilities, expands its footprint across payer-provider network...

BOSTON--(BUSINESS WIRE)--Modella AI Announces Acquisition by AstraZeneca to Advance AI-Driven Oncology R&D at Global Scale...

DUBLIN--(BUSINESS WIRE)--The "Biomedical and ICT Convergence Market by Technology, Solution and Region 2025-2030" report has been added to ResearchAndMarkets.com's offering. This report evaluates the market for convergence between the Information and Communications Technology (ICT) industry and biomedical science and technologies. The report evaluates the latter and analyzes the former in terms of ICT innovation such as connected medical devices. In addition to forecasts for IoT connected healt...

BERKELEY, Calif.--(BUSINESS WIRE)--Vivere Oncotherapies, a UC Berkeley spin-out developing cancer therapies that activate the immune system to detect and destroy cancer cells in immunologically cold tumors, today announced over $10M in funding from YK Bioventures, Pillar, Berkeley Frontier Fund, Freeflow Ventures and The National Cancer Institute. Leveraging technology that enables engineering of targeted immunotherapies, Vivere will develop transformative treatments for difficult-to-treat canc...